Skip to main content

Peer Review reports

From: Podocalyxin is a marker of poor prognosis in colorectal cancer

Original Submission
20 Dec 2013 Submitted Original manuscript
30 Dec 2013 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 2
30 Dec 2013 Submitted Manuscript version 2
5 Feb 2014 Reviewed Reviewer Report - Konstantinos Konstantopoulos
9 Feb 2014 Reviewed Reviewer Report - marius nap
5 Mar 2014 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 3
5 Mar 2014 Submitted Manuscript version 3
19 Mar 2014 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 4
19 Mar 2014 Submitted Manuscript version 4
4 Apr 2014 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 5
4 Apr 2014 Submitted Manuscript version 5
23 May 2014 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 6
23 May 2014 Submitted Manuscript version 6
24 Jun 2014 Author responded Author comments - Tuomas Kaprio
Resubmission - Version 7
24 Jun 2014 Submitted Manuscript version 7
Publishing
2 Jul 2014 Editorially accepted
8 Jul 2014 Article published 10.1186/1471-2407-14-493

You can find further information about peer review here.

Back to article page